All Stories

  1. The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs

    Article • BMC Infectious Diseases, March 2024, Springer Science + Business Media

    A/Prof. Ian John Woolley

  2. Changes in atherosclerotic cardiovascular disease risk over time among people living with HIV

    Article • Journal of Antimicrobial Chemotherapy, February 2024, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  3. Impact of COVID-19 on people with non-functioning spleens in Australia

    Article • Journal of Infection and Public Health, February 2024, Elsevier

    A/Prof. Ian John Woolley

  4. Addressing atherosclerotic cardiovascular disease risk in persons with HIV

    Article • AIDS, October 2023, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  5. More evidence for inequitable COVID-19 outcomes in people with HIV

    Article • AIDS, September 2023, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  6. Primary cardiovascular prevention in people with HIV: what's the score?

    Article • AIDS, March 2023, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  7. Successful expanded clinic network collaboration and patient tracing for retention in HIV care

    Article • AIDS Research and Therapy, December 2022, Springer Science + Business Media

    A/Prof. Ian John Woolley

  8. Human herpes virus 8-related illness: still with us

    Article • AIDS, November 2022, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  9. Long term antibiotic prescribing in the community: 6 years of Australian national data

    Article • Journal of the American Pharmacists Association, November 2022, Elsevier

    A/Prof. Ian John Woolley

  10. New diagnosis of HIV with Cryptococcus neoformans infection presenting as a pleural syndrome

    Article • AIDS, September 2022, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  11. The impact of the COVID-19 pandemic on people with HIV in Victoria, Australia: 1 year later

    Article • AIDS Research and Human Retroviruses, August 2022, Mary Ann Liebert Inc

    A/Prof. Ian John Woolley

  12. Successful Expanded Clinic Network Collaboration and Patient Tracing for Retention in HIV Care

    Article • August 2022, Research Square

    A/Prof. Ian John Woolley

  13. Integrating Hepatitis C Virus Treatment Programs Within Community Mental Health

    Article • Psychiatric Services, August 2022, American Psychiatric Association

    A/Prof. Ian John Woolley

  14. Outcomes in Medicare‐ineligible people living with human immunodeficiency virus in a large healthcare network in Melbourne 2004–2019

    Article • Internal Medicine Journal, May 2022, Wiley

    A/Prof. Ian John Woolley

  15. Congenital asplenia study: clinical and laboratory characterisation of adults with congenital asplenia

    Article • Annals of Hematology, April 2022, Springer Science + Business Media

    A/Prof. Ian John Woolley

  16. Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data

    Article • Clinical Infectious Diseases, April 2022, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  17. When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV

    Article • AIDS, March 2022, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  18. Long-Term Outcomes in Patients on Life-Long Antibiotics: A Five-Year Cohort Study

    Article • Antibiotics, January 2022, MDPI AG

    A/Prof. Ian John Woolley

  19. Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV

    Article • Sexual Health, January 2022, CSIRO Publishing

    A/Prof. Ian John Woolley

  20. Physical function limitation among gay and bisexual men aged ≥55years with and without HIV: findings from the Australian Positive and Peers Longevity Evaluation Study (APPLES)

    Article • Sexual Health, January 2022, CSIRO Publishing

    A/Prof. Ian John Woolley

  21. Hepatitis C virus in people with serious mental illness: An analysis of the care cascade at a tertiary health service with a pilot ‘identify and treat’ strategy

    Article • Internal Medicine Journal, October 2021, Wiley

    A/Prof. Ian John Woolley

  22. SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study

    Article • Human Vaccines & Immunotherapeutics, August 2021, Taylor & Francis

    A/Prof. Ian John Woolley

  23. COVID ‐19: looking backward

    Article • Internal Medicine Journal, August 2021, Wiley

    A/Prof. Ian John Woolley

  24. HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults

    Article • Nature Medicine, June 2021, Springer Science + Business Media

    A/Prof. Ian John Woolley

  25. Underutilised human immunodeficiency virus testing in the setting of invasive pneumococcal disease

    Article • Internal Medicine Journal, June 2021, Wiley

    A/Prof. Ian John Woolley

  26. The Clinical and Financial Burden of Spinal Infections in People who Inject Drugs

    Article • Internal Medicine Journal, May 2021, Wiley

    A/Prof. Ian John Woolley

  27. IgG4-related disease masquerading as a fungating groin lesion in a patient with HIV and incomplete immune reconstitution

    Article • AIDS, March 2021, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  28. The impact of the COVID-19 pandemic on people living with HIV in Victoria, Australia

    Article • AIDS Research and Human Retroviruses, February 2021, Mary Ann Liebert Inc

    A/Prof. Ian John Woolley

  29. A novel case of bilateral tubo-ovarian abscesses attributed to Ruminococcus gnavus without gastrointestinal involvement

    Article • Anaerobe, February 2021, Elsevier

    A/Prof. Ian John Woolley

  30. Routine testing for hyposplenism in a lupus clinic diagnoses; new cases and opportunities for intervention

    Article • Lupus, January 2021, SAGE Publications

    A/Prof. Ian John Woolley

  31. Breaking the fourth wall: Integrating quality into HIV care

    Article • The Indian Journal of Medical Research, January 2021, Medknow

    A/Prof. Ian John Woolley

  32. Trends in practice: attitudes and challenges in the diagnosis, treatment and management of HIV infection in Australia

    Article • Internal Medicine Journal, December 2020, Wiley

    A/Prof. Ian John Woolley

  33. Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study

    Article • November 2020, Cold Spring Harbor Laboratory Press

    A/Prof. Ian John Woolley

  34. Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study

    Article • November 2020, Research Square

    A/Prof. Ian John Woolley

  35. Case Report: Japanese Encephalitis Associated with Chorioretinitis after Short-Term Travel to Bali, Indonesia

    Article • American Journal of Tropical Medicine and Hygiene, October 2020, American Society of Tropical Medicine and Hygiene

    A/Prof. Ian John Woolley

  36. Acceptability of injectable anti-retroviral therapy in Australian travellers with HIV

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2020, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  37. Coronavirus disease 2019 (COVID‐19): not one epidemic but four

    Article • Internal Medicine Journal, June 2020, Wiley

    A/Prof. Ian John Woolley

  38. Platelet phenotype and function in the absence of splenic sequestration (Review)

    Article • Platelets, February 2020, Taylor & Francis

    A/Prof. Ian John Woolley, Sarah Luu

  39. The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single‐tablet regimen in the expanding spectrum of fixed‐dose combination therapy for HIV

    Article • HIV Medicine, February 2020, Wiley

    A/Prof. Ian John Woolley

  40. The burden of infective endocarditis in an Australian cohort of people who inject drugs

    Article • Internal Medicine Journal, December 2019, Wiley

    A/Prof. Ian John Woolley

  41. Intermittent negative blood cultures in Staphylococcus aureus bacteremia; A retrospective study of 1071 episodes

    Article • Open Forum Infectious Diseases, November 2019, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  42. Surveillance of life-long antibiotics—A cross-sectional cohort study assessing patient attitudes and understanding of long-term antibiotic consumption

    Article • Infection Disease & Health, November 2019, Elsevier

    A/Prof. Ian John Woolley

  43. HIV presenting as AIDS in previously undiagnosed tourists in a low-prevalence setting

    Article • AIDS, October 2019, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  44. Review of HIV testing recommendations in Australian specialty guidelines for HIV indicator conditions: a missed opportunity for recommending testing?

    Article • Internal Medicine Journal, September 2019, Wiley

    A/Prof. Ian John Woolley

  45. Post-splenectomy sepsis: preventative strategies, challenges, and solutions

    Article • Infection and Drug Resistance, September 2019, Taylor & Francis

    A/Prof. Ian John Woolley, Sarah Luu

  46. Prevalence and distribution of functional splenic tissue after splenectomy

    Article • Internal Medicine Journal, August 2019, Wiley

    A/Prof. Ian John Woolley, Sarah Luu

  47. Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global Ie DEA Consortium: results from the Site Assessment Survey

    Article • Journal of the International AIDS Society, July 2019, Wiley

    A/Prof. Ian John Woolley

  48. Healthy, safe and effective international medical student electives: a systematic review and recommendations for program coordinators

    Article • Tropical Diseases Travel Medicine and Vaccines, April 2019, Springer Science + Business Media

    A/Prof. Ian John Woolley

  49. Infectious diseases physician attitudes to long-term antibiotic use

    Article • International Journal of Clinical Pharmacy, January 2019, Springer Science + Business Media

    A/Prof. Ian John Woolley

  50. Response to letter to editor regarding Lin et al ‘Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?’

    Article • QJM, January 2019, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  51. Management of gonorrhoea in a hospital network: are we following best practice?

    Article • Sexual Health, January 2019, CSIRO Publishing

    A/Prof. Ian John Woolley

  52. Trends in mortality among ART-treated HIV-infected adults in the Asia-Pacific region between 1999 and 2017: results from the TREAT Asia HIV Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) of IeDEA Asia-Pacific

    Article • Journal of the International AIDS Society, January 2019, Wiley

    A/Prof. Ian John Woolley

  53. Human immunodeficiency virus-infected young people in Australia: data from the Australian HIV Observational Database

    Article • Internal Medicine Journal, December 2018, Wiley

    A/Prof. Ian John Woolley

  54. Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study

    Article • HIV Medicine, November 2018, Wiley

    A/Prof. Ian John Woolley

  55. Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?

    Article • QJM, October 2018, Oxford University Press (OUP)

    Dr Tony Korman, A/Prof. Ian John Woolley

  56. Initial modelling and updates on cost effectiveness from the first 10 years of a spleen registry

    Article • Australian and New Zealand Journal of Public Health, September 2018, Wiley

    A/Prof. Ian John Woolley, Sarah Luu

  57. Are Bone Disease and Cardiovascular Disease Risk Correlated in an HIV Cohort?

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2018, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  58. Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individuals

    Article • AIDS, August 2018, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  59. Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database

    Article • Nephrology, July 2018, Wiley

    A/Prof. Ian John Woolley

  60. Impact of a spleen registry on optimal post-splenectomy vaccination and care

    Article • Human Vaccines & Immunotherapeutics, July 2018, Taylor & Francis

    A/Prof. Ian John Woolley, Sarah Luu

  61. HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia

    Article • HIV Medicine, June 2018, Wiley

    A/Prof. Ian John Woolley

  62. Life-long antimicrobial therapy: where is the evidence?

    Article • Journal of Antimicrobial Chemotherapy, June 2018, Oxford University Press (OUP)

    Dr Tony Korman, A/Prof. Ian John Woolley

  63. Selected state of the art research in internal medicine, 2017

    Article • Internal Medicine Journal, June 2018, Wiley

    Professor Jeff Szer, A/Prof. Ian John Woolley

  64. Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine

    Article • Human Vaccines & Immunotherapeutics, February 2018, Taylor & Francis

    A/Prof. Ian John Woolley

  65. Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus

    Article • Sexual Health, January 2018, CSIRO Publishing

    A/Prof. Ian John Woolley

  66. Increasing Prevalence and Risk of Chronic Kidney Disease in Human Immunodeficiency Virus–Infected Individuals: Changing Demographics Over a 6-Year Period

    Article • The Journal of Infectious Diseases, December 2017, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  67. Understanding of the significance and health implications of asplenia in a cohort of patients with haemaglobinopathy: possible benefits of a spleen registry

    Article • Hematology, December 2017, Taylor & Francis

    A/Prof. Ian John Woolley

  68. Cryptococcal/CSF ventricular levels on MRI brain in a man with AIDS

    Article • Radiology of Infectious Diseases, December 2017, Elsevier

    A/Prof. Ian John Woolley

  69. Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study

    Article • HIV Medicine, July 2017, Wiley

    A/Prof. Ian John Woolley, Dr Colleen M Johnston-Devin

  70. High rates of potentially infectious exposures between immunocompromised patients and their companion animals: an unmet need for education

    Article • Internal Medicine Journal, March 2017, Wiley

    A/Prof. Ian John Woolley

  71. The impact of changes in HIV management guidelines on time to treatment initiation in Australia

    Article • HIV Medicine, February 2017, Wiley

    Dr Tony Korman, A/Prof. Ian John Woolley

  72. Integrase-resistant HIV in an antiretroviral-naive patient in Australia

    Article • AIDS, February 2017, Wolters Kluwer Health

    Dr Tony Korman, A/Prof. Ian John Woolley

  73. Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2017, Springer Science + Business Media

    Dr Tony Korman, A/Prof. Ian John Woolley

  74. Cryptococcemia in primary HIV infection

    Article • International Journal of STD & AIDS, July 2016, SAGE Publications

    Dr Tony Korman, A/Prof. Ian John Woolley

  75. Isn't it time to talk about antiretroviral stewardship?

    Article • Journal of Chemotherapy, July 2016, Maney Publishing

    A/Prof. Ian John Woolley

  76. Maraviroc, as a Switch Option, in HIV-1–infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 4...

    Article • Clinical Infectious Diseases, April 2016, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  77. Tenofovir Therapy for Hepatitis B May Be Commonly Prescribed Without HIV Testing

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2016, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  78. Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study

    Article • Sexual Health, January 2016, CSIRO Publishing

    A/Prof. Ian John Woolley

  79. Treatment and disease outcomes of migrants from low- and middle-income countries in the Australian HIV Observational Database cohort

    Article • AIDS Care, November 2015, Taylor & Francis

    A/Prof. Ian John Woolley

  80. Low rates of endocarditis in healthcare-associated Staphylococcus aureus bacteremia suggest that echocardiography might not always be required

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 2015, Springer Science + Business Media

    Dr Tony Korman, A/Prof. Ian John Woolley

  81. A history of infection with varicella is strongly predictive of the presence of varicella-zoster virus antibodies in a heterogenous Australian HIV cohort

    Article • AIDS, September 2015, Wolters Kluwer Health

    Dr Tony Korman, A/Prof. Ian John Woolley

  82. Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)

    Article • BMC Infectious Diseases, August 2015, Springer Science + Business Media

    Dr Tony Korman, A/Prof. Ian John Woolley

  83. Acute HIV infection presenting as erythema multiforme in a 45-year-old heterosexual man

    Article • The Medical Journal of Australia, August 2015, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Dr Tony Korman, A/Prof. Ian John Woolley

  84. Caught in the act… a case of fulminant amoebic colitis

    Article • JMM Case Reports, August 2015, Society for General Microbiology

    A/Prof. Ian John Woolley

  85. International travel in the immunocompromised patient: a cross-sectional survey of travel advice in 254 consecutive patients

    Article • Internal Medicine Journal, June 2015, Wiley

    A/Prof. Ian John Woolley

  86. Clinic Network Collaboration and Patient Tracing to Maximize Retention in HIV Care

    Article • PLoS ONE, May 2015, PLOS

    A/Prof. Ian John Woolley

  87. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia

    Article • Journal of the International AIDS Society, April 2015, Wiley

    A/Prof. Ian John Woolley

  88. Latent infection in HIV-positive refugees and other immigrants in Australia

    Article • The Medical Journal of Australia, March 2015, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    A/Prof. Ian John Woolley

  89. An analysis of the thromboembolic outcomes of 2472 splenectomized individuals

    Article • Blood, March 2015, American Society of Hematology

    A/Prof. Ian John Woolley

  90. Mycobacterium haemophilumbone and joint infection in HIV/AIDS: case report and literature review

    Article • International Journal of STD & AIDS, January 2015, SAGE Publications

    Dr Tony Korman, A/Prof. Ian John Woolley

  91. Correction: Recent trends in early stage response to combination antiretroviral therapy in Australia

    Article • Antiviral Therapy, January 2015, International Medical Press

    A/Prof. Ian John Woolley

  92. Changes in the prevalence of lipodystrophy, metabolic syndrome and cardiovascular disease risk in HIV-infected men

    Article • Sexual Health, January 2015, CSIRO Publishing

    A/Prof. Ian John Woolley

  93. Acanthamoeba Encephalitis: Isolation of Genotype T1 in Mycobacterial Liquid Culture Medium

    Article • Journal of Clinical Microbiology, December 2014, ASM Journals

    Dr Tony Korman, A/Prof. Ian John Woolley

  94. HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD)

    Article • HIV Medicine, November 2014, Wiley

    Dr Tony Korman, A/Prof. Ian John Woolley

  95. What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore

    Article • Clinical Microbiology and Infection, October 2014, Elsevier

    Associate Professor Eng H. Ooi, A/Prof. Ian John Woolley

  96. Macrophage migration inhibitory factor

    Article • AIDS, July 2014, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  97. Determinants of Viremia Copy-Years in People With HIV/AIDS After Initiation of Antiretroviral Therapy

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2014, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  98. The Significance of HIV ‘Blips’ in Resource-Limited Settings: Is It the Same? Analysis of the Treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD)

    Article • PLoS ONE, February 2014, PLOS

    A/Prof. Ian John Woolley

  99. The significance of low-level viraemia in diverse settings: analysis of the Treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD)

    Article • HIV Medicine, January 2014, Wiley

    A/Prof. Ian John Woolley

  100. Recent trends in early stage response to combination antiretroviral therapy in Australia

    Article • Antiviral Therapy, January 2014, International Medical Press

    A/Prof. Ian John Woolley

  101. C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals

    Article • Sexual Health, January 2014, CSIRO Publishing

    A/Prof. Ian John Woolley

  102. Antiretroviral Treatment Interruption and Loss to Follow-Up in Two HIV Cohorts in Australia and Asia: Implications for ‘Test and Treat’ Prevention Strategy

    Article • AIDS Patient Care and STDs, December 2013, Mary Ann Liebert Inc

    A/Prof. Ian John Woolley

  103. The inside story. Physicians’ views on digital ano-rectal examination for anal cancer screening of HIV positive men who have sex with men

    Article • Journal of Medical Screening, December 2013, SAGE Publications

    A/Prof. Ian John Woolley

  104. HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation

    Article • Journal of the American Heart Association, August 2013, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  105. The two-edged sword: vasculitis associated with HIV and hepatitis C coinfection

    Article • International Journal of STD & AIDS, July 2013, SAGE Publications

    A/Prof. Ian John Woolley

  106. Incidence and risk factors for acute respiratory illnesses and influenza virus infections in Australian travellers to Asia

    Article • Journal of Clinical Virology, May 2013, Elsevier

    A/Prof. Ian John Woolley

  107. Low Risk of Japanese Encephalitis in Short‐Term Australian Travelers to Asia

    Article • Journal of Travel Medicine, May 2013, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  108. Determining research priorities for clinician-initiated trials in infectious diseases

    Article • The Medical Journal of Australia, March 2013, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    A/Prof. Ian John Woolley

  109. Vitamin d deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study

    Article • Journal of Translational Medicine, January 2013, Springer Science + Business Media

    A/Prof. Ian John Woolley

  110. Shooting At the DARC: Potential Issues with Species-Specific Antimalarials

    Article • Infectious Disorders - Drug Targets, November 2012, Bentham Science Publishers

    A/Prof. Ian John Woolley

  111. Visiting friends and relatives may be a risk for non-adherence for HIV-positive travellers

    Article • International Journal of STD & AIDS, November 2012, SAGE Publications

    A/Prof. Ian John Woolley

  112. Successful use of eltrombopag without splenectomy in refractory HIV-related immune reconstitution thrombocytopenia

    Article • AIDS, September 2012, Wolters Kluwer Health

    Dr Tony Korman, A/Prof. Ian John Woolley

  113. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD)

    Article • HIV Medicine, August 2012, Wiley

    A/Prof. Ian John Woolley

  114. Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

    Article • PLoS ONE, June 2012, PLOS

    A/Prof. Ian John Woolley

  115. Acute Mediastinal Melioidosis: Diagnosis By Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

    Article • May 2012, American Thoracic Society

    A/Prof. Ian John Woolley

  116. Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria

    Article • The Medical Journal of Australia, May 2012, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    A/Prof. Ian John Woolley

  117. New HIV diagnosis after occupational exposure screening: the importance of reporting needlestick injuries

    Article • Internal Medicine Journal, February 2012, Wiley

    Dr Tony Korman, A/Prof. Ian John Woolley

  118. Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 2011, Springer Science + Business Media

    A/Prof. Ian John Woolley

  119. CD4 Cell Responses to Combination Antiretroviral Therapy in Patients Starting Therapy at High CD4 Cell Counts

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2011, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  120. Rat bite fever as a presenting illness in a patient with AIDS

    Article • Infection, August 2011, Springer Science + Business Media

    Dr Tony Korman, A/Prof. Ian John Woolley

  121. Splenectomy Associated Changes in IgM Memory B Cells in an Adult Spleen Registry Cohort

    Article • PLoS ONE, August 2011, PLOS

    A/Prof. Ian John Woolley

  122. Low CD4 Count Is Associated With an Increased Risk of Fragility Fracture in HIV-Infected Patients

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2011, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  123. Comment on: The DART Trial: 'The Doctor's Dilemma' revisited

    Article • Journal of Antimicrobial Chemotherapy, June 2011, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  124. The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHOD

    Article • Journal of the International Association of Physicians in AIDS Care, April 2011, SAGE Publications

    A/Prof. Ian John Woolley

  125. N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients

    Article • AIDS, March 2011, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  126. Trends in detectable viral load by calendar year in the Australian HIV observational database

    Article • Journal of the International AIDS Society, January 2011, Wiley

    A/Prof. Ian John Woolley

  127. Triple class experience after initiation of combination antiretroviral treatment in Australia: survival and projections

    Article • Sexual Health, January 2011, CSIRO Publishing

    A/Prof. Ian John Woolley

  128. Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

    Article • AIDS, November 2010, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  129. The Influence of Splenectomy on the Infectious Complications and Outcomes of people With HIV: Marked, Sustained Elevation in Risk of Severe Infection With Bacteria Including Streptococcus pneumoniae

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2010, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  130. Cardiac computed tomography in endocarditis

    Article • Heart, August 2010, BMJ

    A/Prof. Ian John Woolley

  131. Autoimmune haemolytic anaemia: an unusual presentation of HIV seroconversion disease

    Article • AIDS, July 2010, Wolters Kluwer Health

    Dr Tony Korman, A/Prof. Ian John Woolley

  132. CORRIGENDUM

    Article • ANZ Journal of Surgery, November 2009, Wiley

    A/Prof. Ian John Woolley

  133. Re: Published article - patient knowledge of the risks of post-splenectomy sepsisANZ J. Surg.2008; 78: 867-70

    Article • ANZ Journal of Surgery, November 2009, Wiley

    A/Prof. Ian John Woolley

  134. Duffy antigen expression on reticulocytes does not alter following blood loss in an autologous donation model

    Article • Vox Sanguinis, October 2009, Wiley

    A/Prof. Ian John Woolley

  135. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management

    Article • Clinical Microbiology and Infection, July 2009, Elsevier

    Dr Tony Korman, A/Prof. Ian John Woolley

  136. Duffy Antigen Polymorphisms Do Not Alter Progression of HIV in African Americans in the MACS Cohort

    Article • Cell Host & Microbe, May 2009, Elsevier

    A/Prof. Ian John Woolley

  137. Shedding light on DARC: the role of the Duffy antigen/receptor for chemokines in inflammation, infection and malignancy

    Article • Inflammation Research, March 2009, Springer Science + Business Media

    A/Prof. Ian John Woolley

  138. HIV infection and high density lipoprotein metabolism

    Article • Atherosclerosis, July 2008, Elsevier

    A/Prof. Ian John Woolley

  139. Guidelines for the prevention of sepsis in asplenic and hyposplenic patients

    Article • Internal Medicine Journal, May 2008, Wiley

    A/Prof. Ian John Woolley

  140. Unrecognised vitamin D deficiency: low concentrations in African migrants with HIV in Australia

    Article • Sexual Health, January 2008, CSIRO Publishing

    Dr Tony Korman, A/Prof. Ian John Woolley

  141. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993?2006

    Article • HIV Medicine, September 2007, Wiley

    A/Prof. Ian John Woolley

  142. Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART

    Article • Journal of the International Association of Physicians in AIDS Care, June 2007, SAGE Publications

    A/Prof. Ian John Woolley

  143. Acute pancreatitis caused by tipranavir/ritonavir-induced hypertriglyceridaemia

    Article • AIDS, February 2007, Wolters Kluwer Health

    Dr Tony Korman, A/Prof. Ian John Woolley

  144. Macrolide use and the risk of vascular disease in HIV-infected men in the Multicenter AIDS Cohort Study

    Article • Sexual Health, January 2007, CSIRO Publishing

    A/Prof. Ian John Woolley

  145. Cambodian-born individuals diagnosed with HIV in Victoria: epidemiological findings and health service implications

    Article • Sexual Health, January 2007, CSIRO Publishing

    A/Prof. Ian John Woolley

  146. Cost-effectiveness of a post-splenectomy registry for prevention of sepsis in the asplenic

    Article • Australian and New Zealand Journal of Public Health, December 2006, Wiley

    A/Prof. Ian John Woolley

  147. Occupational exposures experienced by medical students during overseas electives

    Article • Australian Infection Control, December 2006, Elsevier

    A/Prof. Ian John Woolley

  148. Rat-bite fever septic arthritis: illustrative case and literature review

    Article • European Journal of Clinical Microbiology & Infectious Diseases, November 2006, Springer Science + Business Media

    Dr Tony Korman, A/Prof. Ian John Woolley

  149. ADHERENCE TO GUIDELINES FOR PREVENTION OF POSTSPLENECTOMY SEPSIS. AGE AND SEX ARE RISK FACTORS: A FIVE-YEAR RETROSPECTIVE REVIEW

    Article • ANZ Journal of Surgery, July 2006, Wiley

    A/Prof. Ian John Woolley

  150. A randomised controlled trial of omega-3 fatty acid supplementation for the treatment of hypertriglyceridemia in HIV-infected males on highly active antiretroviral therapy

    Article • Sexual Health, January 2006, CSIRO Publishing

    A/Prof. Ian John Woolley

  151. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment

    Article • Metabolism, January 2006, Elsevier

    A/Prof. Ian John Woolley

  152. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database

    Article • HIV Medicine, May 2005, Wiley

    Dr Tony Korman, A/Prof. Ian John Woolley

  153. Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction

    Article • Internal Medicine Journal, January 2005, Wiley

    A/Prof. Ian John Woolley

  154. Eosinophilic folliculitis

    Article • AIDS, November 2004, Wolters Kluwer Health

    Dr Tony Korman, A/Prof. Ian John Woolley

  155. The Use of Antibiotics as Secondary Prevention for Cardiac Events

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2004, Wiley

    A/Prof. Ian John Woolley

  156. Lichenoid drug eruption to tenofovir in an HIV/hepatitis B virus co-infected patient

    Article • AIDS, September 2004, Wolters Kluwer Health

    Dr Tony Korman, A/Prof. Ian John Woolley

  157. Chlamydia pneumoniae in HIV-infected patients and controls assessed by a novel whole blood interferon-γ assay, serology and PCR

    Article • Clinical Microbiology and Infection, September 2004, Elsevier

    A/Prof. Ian John Woolley

  158. Clostridium septicum Bacteremia Without Gas Gangrene as a Late Consequence of a Contaminated Wound

    Article • Surgical Infections, September 2004, Mary Ann Liebert Inc

    A/Prof. Ian John Woolley

  159. Fragility Fractures in HIV-Infected Patients: Need for Better Understanding of Diagnosis and Management

    Article • Journal of the International Association of Physicians in AIDS Care, July 2004, SAGE Publications

    A/Prof. Ian John Woolley

  160. Disseminated Mycobacterium avium-intracellulare Complex (MAC) Infection in the Era of Effective Antiretroviral Therapy

    Article • Drugs, January 2004, Springer Science + Business Media

    A/Prof. Ian John Woolley

  161. Sequential cutaneous drug reactions to protease inhibitors in the context of occupational post-exposure prophylaxis

    Article • AIDS, July 2003, Wolters Kluwer Health

    Dr Tony Korman, A/Prof. Ian John Woolley

  162. Effect of GB Virus C Coinfection on Response to Antiretroviral Treatment in Human Immunodeficiency Virus–Infected Patients

    Article • The Journal of Infectious Diseases, February 2003, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  163. Changing Spectrum of Mortality Due to Human Immunodeficiency Virus: Analysis of 260 Deaths during 1995-1999

    Article • Clinical Infectious Diseases, May 2001, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  164. Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of theP. vivaxligand required for blood-stage infection

    Article • FEBS Letters, April 2001, Wiley

    John Adams, A/Prof. Ian John Woolley

  165. Letter to the Editor

    Article • Clinical Immunology, March 2001, Elsevier

    A/Prof. Ian John Woolley

  166. Differential expression of the Duffy antigen receptor for chemokines according to RBC age and FY genotype

    Article • Transfusion, August 2000, Wiley

    A/Prof. Ian John Woolley

  167. Emergence of FY*A null in a Plasmodium vivax -endemic region of Papua New Guinea

    Article • Proceedings of the National Academy of Sciences, November 1999, Proceedings of the National Academy of Sciences

    A/Prof. Ian John Woolley

  168. Human Immunodeficiency Virus 1 Protease Inhibitors in Clinical Practice

    Article • Archives of Internal Medicine, August 1999, American Medical Association (AMA)

    A/Prof. Ian John Woolley

  169. GBV-C/HGV infection in HIV-infected patients

    Article • Clinical Microbiology and Infection, April 1999, Elsevier

    A/Prof. Ian John Woolley

  170. Hepatitis G Virus RNA Is Common in AIDS Patients' Plasma but Is Not Associated With Abnormal Liver Function Tests or Other Clinical Syndromes

    Article • Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, December 1998, Wolters Kluwer Health

    A/Prof. Ian John Woolley

  171. Transmissible spongiform encephalopathy and new variantCreutzfeldt-Jakob disease

    Article • Clinical Microbiology Newsletter, October 1998, Elsevier

    A/Prof. Ian John Woolley

  172. Piroplasmosis

    Article • Clinical Microbiology Newsletter, February 1998, Elsevier

    A/Prof. Ian John Woolley

  173. Postpartum Epidural Abscess Due to Group BStreptococcus

    Article • Clinical Infectious Diseases, November 1997, Oxford University Press (OUP)

    A/Prof. Ian John Woolley

  174. Diffuse alveolar damage following a single administration of a cyclophosphamide containing chemotherapy regimen

    Article • Australian and New Zealand Journal of Medicine, October 1997, Wiley

    A/Prof. Ian John Woolley

  175. CD4 lymphocyte counts in HIV/AIDS patients with intercurrent illness

    Article • AIDS, June 1996, Wolters Kluwer Health

    A/Prof. Ian John Woolley